A007390 Stock Overview
NatureCell Co.,Ltd. engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
NatureCell Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩9,380.00 |
| 52 Week High | ₩11,270.00 |
| 52 Week Low | ₩6,880.00 |
| Beta | 0.41 |
| 1 Month Change | 10.48% |
| 3 Month Change | 17.10% |
| 1 Year Change | -11.76% |
| 3 Year Change | -12.74% |
| 5 Year Change | -19.83% |
| Change since IPO | 418.23% |
Recent News & Updates
Shareholder Returns
| A007390 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 8.4% | 4.2% | 0.8% |
| 1Y | -11.8% | 7.3% | 6.3% |
Return vs Industry: A007390 underperformed the KR Biotechs industry which returned 7.3% over the past year.
Return vs Market: A007390 underperformed the KR Market which returned 6.3% over the past year.
Price Volatility
| A007390 volatility | |
|---|---|
| A007390 Average Weekly Movement | 8.8% |
| Biotechs Industry Average Movement | 7.8% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A007390's share price has been volatile over the past 3 months.
Volatility Over Time: A007390's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 79 | Jeong-Chan Ra | www.naturecell.co.kr |
NatureCell Co.,Ltd. engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea. The company’s products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and other ETC products under the SAMMI and OEM brands.
NatureCell Co.,Ltd. Fundamentals Summary
| A007390 fundamental statistics | |
|---|---|
| Market cap | ₩601.79b |
| Earnings (TTM) | -₩11.44b |
| Revenue (TTM) | ₩19.35b |
31.1x
P/S Ratio-52.6x
P/E RatioIs A007390 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007390 income statement (TTM) | |
|---|---|
| Revenue | ₩19.35b |
| Cost of Revenue | ₩11.16b |
| Gross Profit | ₩8.19b |
| Other Expenses | ₩19.63b |
| Earnings | -₩11.44b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -178.28 |
| Gross Margin | 42.33% |
| Net Profit Margin | -59.11% |
| Debt/Equity Ratio | 0% |
How did A007390 perform over the long term?
See historical performance and comparison